Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mismatch Repair

Mismatch Repair

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Mutations

Mutations

Mutations

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...

Exon Recombination

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Programmable mRNA 3'UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer.

Nature biomedical engineering·2026

Same author

Emerging therapies to overcome antiandrogen resistance and beyond in lethal prostate cancer.

Journal of the National Cancer Center·2026

Same author

Single-dose cathepsin L CRISPR nanotherapy mitigates PASC-like lung damage in hamsters.

Nano research·2025

Same author

Highly quantitative measurement of differential protein-genome binding with PerCell chromatin sequencing.

Cell reports methods·2025

Same author

SCORT-Cas13d Nanotherapy Precisely Targets the 'Undruggable' Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Same author

Integrative analysis identifies the atypical repressor E2F8 as a targetable transcriptional activator driving lethal prostate cancer.

Oncogene·2024

Search research articles

Related Experiment Video

Updated: May 20, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Mapping mutations in prostate cancer exomes.

Benjamin Sunkel¹, Qianben Wang

¹Ohio State Biochemistry Graduate Program, The Ohio State University College of Medicine, Columbus, OH 43210, USA.

Asian Journal of Andrology

|July 31, 2012

Summary

This summary is machine-generated.

Identifying driver mutations in prostate cancer enhances understanding and treatment. Recent studies analyzed primary and lethal castration-resistant prostate cancer (CRPC) to reveal novel mutations defining subtypes.

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Related Experiment Videos

Last Updated: May 20, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

Area of Science:

Oncology
Genetics
Genomics

Background:

Prostate cancer (PC) is a leading cause of cancer-related death.
Identifying driver mutations is crucial for understanding PC pathogenesis and developing targeted therapies.
Previous studies have focused on specific PC subtypes or smaller cohorts.

Discussion:

Exome sequencing revealed novel genetic mutations in prostate cancer.
These mutations represent uncharacterized drivers of the disease.
Combinations of mutations may define distinct prostate cancer subtypes.

Key Insights:

Identification of novel driver mutations in prostate cancer.
Discovery of mutation combinations that may define subtypes.
Enhanced understanding of prostate cancer's molecular landscape.

Outlook:

Potential for new targeted therapies based on identified mutations.
Improved stratification of patients for personalized treatment approaches.
Further research into the functional roles of uncharacterized drivers.